Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 28. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_4509AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell100% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4510AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.001mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell75% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4511AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.0025mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell75% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4512AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.005mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell62% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4513AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell90% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4514AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.001mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell70% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4515AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.0025mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell70% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4516AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.005mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell70% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4517AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell40% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4518AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.001mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell35% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4519AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.0025mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell30% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4520AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.005mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell35% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4521AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell18% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4522AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.001mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell15% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4523AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.0025mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell15% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4524AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.005mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell15% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4525AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell100% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4526AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.0075mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell90% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4527AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.05mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell80% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4528AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell80% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4529AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.0075mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell70% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4530AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.05mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell62% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4531AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell40% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4532AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.0075mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell40% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4533AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.05mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell40% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4534AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell20% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4535AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.0075mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell20% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4536AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with Cyclophosphamide (0.05mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1000 VP/cell20% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453